Clinical Trial of Growth Hormone in MPS I, II, and VI

NCT00748969 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Insufficient recruitment.

Conditions

Mucopolysaccharidosis I
Mucopolysaccharidosis II
Mucopolysaccharidosis VI

Interventions

DRUG: Somatropin (DNA origin)

Sponsor

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center